Title : Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism.

Pub. Date : 2020 May 5

PMID : 32312817






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism. triptolide isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens
2 Our findings showed that triptolide, a diterpenoid epoxide from Tripterygium wilfordii, served as a potent Nrf2 inhibitor, which exhibited selective cytotoxicity to patient-derived IDH1-mutated glioma cells in vitro and in vivo. triptolide isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens
3 Mechanistically, triptolide compromised the expression of GCLC, GCLM, and SLC7A11, which disrupted glutathione metabolism and established synthetic lethality with reactive oxygen species derived from IDH1 mutant neomorphic activity. triptolide isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens
4 Our findings highlight triptolide as a valuable therapeutic approach for IDH1-mutated malignancies by targeting the Nrf2-driven glutathione synthesis pathway. triptolide isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens